Increase in renal medullary nitric oxide synthase activity protects from norepinephrine-induced hypertension

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 418-423

  Szentiványi Jr , Mátyás ^a   Zou, Ai Ping ^b   Maeda, Celso Y ^c   Mattson, David L ^b   Cowley Jr , Allen W ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c NONE

Author keywords

Nitric oxide synthase; Norepinephrine; Rats; Rauwolscine; Receptors, adrenergic, alpha

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ARGININE; ARGININE METHYL ESTER; CITRULLINE; NITRIC OXIDE SYNTHASE; NORADRENALIN; RAUWOLSCINE;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0342514748     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.418     Document Type: Conference Paper

References (31)

1. Zou AP, Cowley AW Jr. Increased NO production modulates adrenergic response of renal medullary circulation in rats. FASEB J. 1998;12: A53. Abstract.
2. Sai Y, Silldorf EP. Pallone TL. Effect of norepinephrine and acetylcholine on outer medullary descending vasa recta. Am J Physiol. 1995; 269:H710-H716.
3. Cowley AW Jr, Mattson DL, Lu S, Roman RJ. The renal medulla and hypertension. Hypertension. 1995;25:663-673.
4. Cowley AW Jr. Role of the renal medulla in volume and arterial pressure regulation. Am J Physiol. 1997;273:R1-R15.
5. Roman RJ, Zou AP. Influence of the renal medullary circulation on the control of sodium excretion. Am J Physiol. 1993;265:R963-R973.
6. Mattson DL, Lu S, Nakanishi K, Papanek E, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 1994;266:H1918-H1926.
7. Nakanishi K, Mattson DL, Cowley AW Jr. Role of renal medullary blood flow in the development of L-NAME hypertension in rats. Am J Physiol. 1995;268:R317-R323.
8. Cowley AW Jr, Skelton MM, Kurth TM. Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial blood pressure. Am J Physiol. 1998;275:R1420-R1424.
9. Szentiványi M Jr, Maeda CY, Cowley AW Jr. Local renal medullary L-NAME infusion enhances the effect of chronic angiotensin-II treatment. Hypertension. 1999;33:440-445.
10. Szentiványi M Jr, Park F, Maeda CY, Cowley AW Jr. Nitric oxide in the renal medulla protects from vasopressin-induced hypertension. Hypertension. In press.
11. Vanhoutte PM, Miller VM. Alpha-2 adrenoceptors and endotheliumderived relaxing factor. Am J Med. 1989;87:1S-5S.
12. Wu F, Park F, Cowley AW Jr, Mattson DL. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am J Physiol. 1999;276:F874-F881.
13. Lu S, Mattson DL, Roman RJ, Becker CG, Cowley AW Jr. Assessment of changes in intrarenal blood flow in conscious rat using laser-Doppler flowmetry. Am J Physiol. 1993;246:F956-F962.
14. Kleinjans J, Kasbergen C, Vervoort-Peters L, Smits J, Struyker Boudier HAJ. Chronic intravenous infusion of noradrenaline produces labile hypertension in conscious rats. Life Sci. 1981;29:509-514.
15. Zou AP, Wu F, Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension. 1998;31:271-276.
16. Hermansson K, Ojte GG, Wolgast M. The cortical and medullary blood flow at different blood levels of renal nerve activity. Acta Physiol Scand. 1984;120:161-169.
17. Park F, Zou AP, Cowley AW Jr. Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla. Hypertension. 1998; 32:896-901.
18. Hennington BS, Zhang H, Miller MT, Granger JP, Reckelhoff JF. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension. 1998;31:283-288.
19. Simonian SX, Herbison AE. Localization of neuronal nitric oxide synthase-immunoreactivity within sub-populations of noradrenergic A1 and A2 neurons in the rat. Brain Res. 1996;732:247-252.
20. Mattson DL, Bellehumeur TG. Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension. 1996;28:297-303.
21. Thorin E, Huang PL, Fishman MC, Bevan JA. Nitric oxide inhibits alpha-2 adrenoceptor mediated endothelium dependent vasodilation. Circ Res. 1998;82:1323-1329.
22. 2-adrenergic coronary vasoconstriction during exercise in the ischemic heart. Circ Res. 1997;80:196-207.
23. Lembo G, Iaccarino G, Vecchione C, Barbato E, Izzo R, Fontana D, Trimarco B. Insulin modulation of an endothelial nitric oxide component present in the alpha-2 and beta adrenergic responses in human forearm. J Clin Invest. 1997;100:2007-2014.
24. Liao JK, Homey CJ. The release of endothelium-derived relaxing factor via alpha-2 adrenergic receptor activation is specifically mediated by Gi alpha2. J Biol Chem. 1993;268:19528-19533.
25. Thompson SC, Vallon V. Alpha-2 adrenoceptors determine the response to nitric oxide inhibition in the rat glomerulus and proximal tubule. J Am Soc Nephrol. 1995;6:1482-1490.
26. Kanagy NL. Increased vesicular responsiveness to alpha-2 adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol. 1997;273:H2756-H2764.
27. Lu S, Mattson DL, Cowley AW Jr. Renal medullary captopril delivery lowers blood pressure in spontaneously hypertensive rats. Hypertension. 1994;23:337-345.
28. Vallon V, Peterson OW, Gabbai FB, Blantz RC, Thompson SC. Interactive control of renal function by alpha-2 adrenergic system and nitric oxide: role of angiotensin II. J Cardiovasc Pharmacol. 1995;26:916-922.
29. Intengan HD Smyth DD. Alpha-2a/d adrenoceptor subtype stimulation by guanfacine increases osmolar clearance. J Pharmacol Exp Ther. 1997; 281:48-53.
30. Pettinger WA. Renal alpha-2 receptors and hypertension. Hypertension. 1987;9:3-6.
31. Ginn DI, Baptista CA, Alam KY, Deng AY, Dene H, Le H, Kurtz, W. Rapp JP. Genetic analysis of alpha-2 adrenergic receptors and blood pressure using Dahl salt-sensitive rats. J Hypertens. 1994;12:357-365.